Cat.#: ACPP-1320
Despition | FGFR4 Blocking Peptide for Immunodepletion, Immunocompetition |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1617 | Human PARK2 Protein (AC1617) | 5 µg | inquiry |
ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg | inquiry |
ACPP-1534 | Human RLN3 Protein (AC1534) | 5 µg | inquiry |
ACPP-1794 | Human BAIAP2 Protein (AC1794) | 5 µg | inquiry |
ACPP-1528 | Human RCAN3 Protein (AC1528) | 2 µg | inquiry |
ACPP-1333 | Nurr1 Blocking Peptide (AC1333) | 250 µg | inquiry |
ACPP-1769 | Human VAT1 Protein (AC1769) | 2 µg | inquiry |
ACPP-1040 | Recombinant Mouse Eph Receptor A2 Protein (6×His Tag) (AC1040) | 50 µg | inquiry |
ACPP-1726 | Human Midkine Protein (AC1726) | 5 µg | inquiry |
ACPP-1777 | Human Acrp30 Protein (AC1777) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.